Virology News and Research

Latest Virology News and Research

Alnylam third quarter 2012 revenues decrease to $16.8 million

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter 2012, and company highlights.

6 Nov 2012

Virttu launches REPLICATE- Open Innovation Forum

Virttu Biologics Limited, a UK biotechnology company with expertise in the field of oncolytic viruses, has announced the launch of the Virttu REPLICATE- Open Innovation Forum.

6 Nov 2012

Adenovirus detection not uncommon among children with Kawasaki disease

Clinicians should take caution when diagnosing a child who has a high fever and whose tests show evidence of adenovirus, and not assume the virus is responsible for Kawasaki-like symptoms. According to a new study from Nationwide Children's Hospital appearing in Clinical Infectious Diseases, adenovirus detection is not uncommon among children with Kawasaki disease.

5 Nov 2012

Inhibition of NOX4 enzyme plays an important role in liver fibrosis

Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have led a study published in PLoS One showing that the inhibition of a family member of NADPH oxidase enzyme, NOX4, plays an important role in liver fibrosis.

5 Nov 2012

Cervical cancer risk remains high after CIN treatment

Women who undergo treatment for screening-detected cervical intraepithelial neoplasia are more than four times more likely to develop cervical cancer than women with normal smear tests, research suggests.

5 Nov 2012

Weill Cornell researchers awarded Grand Challenges Explorations grants

Weill Cornell Medical College announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.

3 Nov 2012

Phase II study to evaluate Medivir/Janssen's simeprevir and Vertex against HCV

Medivir AB, announced today plans for a phase II proof-of-concept study of an all-oral regimen for the treatment of hepatitis C containing of Medivir/Janssen's protease inhibitor simeprevir and Vertex's nucleotide analogue hepatitis C virus (HCV) polymerase inhibitor VX-135.

3 Nov 2012

HPV test of cure cheaper and more effective than cytology testing for women following pre-cervical cancer treatment

Testing women to see if they are cured of HPV (the virus that can cause genital warts and cervical cancer) following treatment for abnormal cells on the surface of the cervix is more effective and cheaper than cytology testing (cervical screening) alone, suggests a study published on bmj.com.

2 Nov 2012

Study shows reduced risk of liver-related mortality in African American women with HIV/HCV

A new study shows that African American women coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are less likely to die from liver disease than Caucasian or Hispanic women. Findings in the November issue of Hepatology, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases, indicate that lower liver-related mortality in African American women was independent of other causes of death.

1 Nov 2012

Microbiologists confirm existence of new tick disease in Switzerland

Until now, we knew that ticks primarily transmit two pathogens to humans in Switzerland: the bacterium Borrelia burgdorferi - which causes borreliosis - and the early-summer-meningoencephalitis virus, which can cause cerebral inflammation. Now, microbiologists from the University of Zurich confirm the existence of another tick disease in Switzerland - neoehrlichiosis.

1 Nov 2012

Experimental HIV test might help improve diagnosis, treatment in developing countries

"Scientists have come up with a test for the virus that causes AIDS that is 10 times more sensitive and a fraction of the cost of existing methods, offering the promise of better diagnosis and treatment in the developing world," Reuters reports.

1 Nov 2012

Scientists solve mystery behind what triggers the herpes virus to become active again

The mere mention of the word "herpes" usually conjures negative images and stereotypes, but most people have been infected with some form of the virus. For most, a sore appears, heals and is forgotten, although the virus remains latent just waiting for the right circumstances to come back. Now, the mystery behind what triggers the virus to become active again is closer to being solved thanks to new research published in the Journal of Leukocyte Biology's November 2012 issue.

1 Nov 2012

African American women coinfected with HIV and HCV less likely to die from liver disease than Caucasian or Hispanic women

31 Oct 2012

BioCryst announces withdrawal of BCX5191 IND following discussion with FDA

BioCryst Pharmaceuticals, Inc. announced the withdrawal of its Investigational New Drug application (IND) for the antiviral nucleoside, BCX5191, following a discussion with the U.S. Food and Drug Administration (FDA).

31 Oct 2012

All health care workers should be vaccinated with annual flu vaccine to protect patients

All health care workers in health care institutions should be vaccinated with the annual influenza vaccine to protect patients, argues an editorial in CMAJ (Canadian Medical Association Journal).

30 Oct 2012

RUB-medical researchers receive $2.3M Gates Foundation grant for HIV vaccine research

To support their research for a vaccine against the HI-Virus, Prof. Dr. Klaus Überla of the Faculty for Medicine at the Ruhr-Universität Bochum and his research team will receive $2.3 million in funding within the next three years from the Bill & Melinda Gates Foundation. The scientists are part of the Collaboration for AIDS Vaccine Discovery (CAVD), which seeks to speed up the development of an HIV-vaccine through a rigorous exchange of information, methods and reagents.

29 Oct 2012

New HIV test for babies differs from conventional test, delivers diagnosis in less than an hour

Today, mothers in Africa sometimes walk more than 10 miles to a clinic only to learn that conventional HIV test results for their babies are not available yet.

29 Oct 2012

UNICEF calls for 'finishing' global polio eradication; Rotary International warns of funding shortfall in India

UNICEF on Wednesday "called for continued dedication in 'finishing the job' in eradicating polio, while also applauding India for being 'declared polio free' for the first time in history," Xinhua reports. "UNICEF Executive Director Anthony Lake said in a statement released … on World Polio Day, which falls on Oct. 24, that 'fewer children than ever before suffer the debilitating effects of this cruel disease,'" the news service writes.

26 Oct 2012

Population Health Management discusses latest information on shingles and PHN

Shingles, a reactivation of the herpes zoster (chickenpox) virus affects nearly 1 in 3 Americans. About 1 million cases are diagnosed each year, with some patients suffering excruciating pain and itching due to post-herpetic neuralgia (PHN), a complication of the viral infection that can last for years despite treatment.

26 Oct 2012

Guidelines to help protect vulnerable populations from flu

While it is important to get vaccinated against the flu virus as early as possible, it is never too late to reap the benefits of this vaccine. According to The Centers for Disease Control and Prevention, the peak months for the spread of the flu virus are January and February and the season can last into mid-May.

26 Oct 2012

Virology News and Research

Latest Virology News and Research

Alnylam third quarter 2012 revenues decrease to $16.8 million

Virttu launches REPLICATE- Open Innovation Forum

Adenovirus detection not uncommon among children with Kawasaki disease

Inhibition of NOX4 enzyme plays an important role in liver fibrosis

Cervical cancer risk remains high after CIN treatment

Weill Cornell researchers awarded Grand Challenges Explorations grants

Phase II study to evaluate Medivir/Janssen's simeprevir and Vertex against HCV

HPV test of cure cheaper and more effective than cytology testing for women following pre-cervical cancer treatment

Study shows reduced risk of liver-related mortality in African American women with HIV/HCV

Microbiologists confirm existence of new tick disease in Switzerland

Experimental HIV test might help improve diagnosis, treatment in developing countries

Scientists solve mystery behind what triggers the herpes virus to become active again

African American women coinfected with HIV and HCV less likely to die from liver disease than Caucasian or Hispanic women

BioCryst announces withdrawal of BCX5191 IND following discussion with FDA

All health care workers should be vaccinated with annual flu vaccine to protect patients

RUB-medical researchers receive $2.3M Gates Foundation grant for HIV vaccine research

New HIV test for babies differs from conventional test, delivers diagnosis in less than an hour

UNICEF calls for 'finishing' global polio eradication; Rotary International warns of funding shortfall in India

Population Health Management discusses latest information on shingles and PHN

Guidelines to help protect vulnerable populations from flu

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep